Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Saved in:
| Title: | Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). |
|---|---|
| Authors: | Barajas RF; Department of Radiology, Neuroradiology Section, Oregon Health & Science University, Portland Oregon, USA.; Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, USA.; Knight Cancer Institute Translational Oncology Program, Oregon Health & Science University, Portland, Oregon, USA., Politi LS; Humanitas University and Humanitas Research and Clinical Center - IRCCS, Milan, Italy.; Boston Children's Hospital, Boston, Massachusetts, USA., Anzalone N; Neuroradiology Unit, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, School of Medicine, University of Nottingham, Nottingham, UK., Boxerman JL; Department of Diagnostic Imaging, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA., Kaufmann TJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Quarles CC; Department of Neuroimaging Research & Barrow Neuroimaging Innovation Center, Barrow Neurological Institute, Phoenix, Arizona, USA., Ellingson BM; UCLA Brain Tumor Imaging Laboratory (BTIL), Departments of Radiological Sciences and Psychiatry, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, USA.; Departments of Radiological Sciences, Psychiatry, and Biobehavioral Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, USA., Auer D; Versus Arthritis Pain Centre, University of Nottingham, Nottingham, UK.; NIHR Nottingham Biomedical Research Centre, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, UK., Andronesi OC; A. A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA., Ferreri AJM; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mrugala MM; Department of Medicine, Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona, USA.; Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA., Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Neurology, Weill Cornell Medical School, New York, New York, USA., Neuwelt EA; Blood-Brain Barrier Program, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA.; Portland Veterans Affairs Medical Center, Portland, Oregon, USA., Ambady P; Blood-Brain Barrier Program, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA., Rubenstein JL; Division of Hematology/Oncology, University of California, San Francisco, California, USA.; Department of Medicine, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Illerhaus G; Clinic of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany., Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan., Batchelor TT; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hu LS; Department of Radiology, Neuroradiology Division, Mayo Clinic, Phoenix, Arizona, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2021 Jul 01; Vol. 23 (7), pp. 1056-1071. |
| Publication Type: | Consensus Statement; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
